Cell Signaling Technology, Inc. Granted Patent for PCR Methods for Detection of a Subset of Treatable Non-Small Cell Lung Cancers
1/7/2013 9:05:14 AM
More...
|
Cell Signaling Technology, Inc. Develops Novel Monoclonal Antibody Discovery Platform
5/11/2012 10:43:47 AM
More...
|
Ventana Medical Systems, Inc. (VMSI) to Collaborate with Pfizer Inc. (PFE) and Cell Signaling Technology, Inc. on Companion Diagnostic to Identify Lung Cancer Patients with ALK Gene Rearrangements
1/10/2012 7:23:50 AM
More...
|
Cell Signaling Technology, Inc. Wins Life Science Industry Awards in “Best Performing Antibodies” and “Best Breakthrough Products Cancer Research” Categories
12/5/2011 6:43:02 AM
More...
|
Cell Signaling Technology, Inc. Wins Life Science Industry Awards in “Best Performing Antibodies” and “Best Breakthrough Products Cancer Research” Categories
12/5/2011 6:12:11 AM
More...
|
Cell Signaling Technology, Inc. Grants a Patent License to Pfizer Inc. (PFE)
7/6/2011 11:03:09 AM
More...
|
Cell Signaling Technology, Inc. Announces License in Personalized Cancer Diagnostics
3/15/2011 10:31:20 AM
More...
|
Cell Signaling Technology, Inc. Announces Joint Commercialization Partnership with Astellas Pharma Inc. (YPH.BE) in Cancer Personalized Medicine
2/23/2011 8:34:05 AM
More...
|
Cell Signaling Technology, Inc. Acquires BIOKE and Expands Operations to Europe
7/9/2009 9:01:13 AM
More...
|
Cell Signaling Technology, Inc. Announces Renewal of PhosphoScan(R) Proteomics Research Project for Lead Compound Biomarker Discovery
11/11/2008 11:35:31 AM
More...
|
|